Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern
ABSTRACT Background To inform future preventive measures including repeated vaccinations, we have searched for a clinically useful immune correlate of protection against fatal Covid-19 among nursing homes residents.Methods We performed repeated capillary blood sampling with analysis of S-binding IgG in an open cohort study with inclusion of nursing home residents in Sweden. We analyzed immunological and registry data collected from September 2021 with end of follow-up 31 August 2022. The study period included implementation of the 3rd and 4th mRNA monovalent vaccine doses and Omicron virus waves.Findings A total of 3012 nursing home residents with median age 86 were enrolled. The 3rd mRNA dose elicited a 99-fold relative increase of S-binding IgG among 2606 blood-sampled individuals and corresponding increase of neutralizing antibodies. The 4th mRNA vaccine dose boosted the levels 3.8-fold. Half-life of S-binding IgG was 72 days. A total 528 residents acquired their first SARS-CoV-2 infection after the 3rd or the 4th vaccine dose and the 30-day mortality was 9.1%. We found no indication that levels of vaccine-induced antibodies protected against infection with Omicron VOCs. In contrast, the risk of death was inversely correlated to levels of S-directed IgG below the 20thpercentile. The risk plateaued at population average above lower 35th percentile of S-binding IgG.Interpretation In the absence of neutralizing antibodies that protection from infection, quantification of S-binding IgG post vaccination may be useful to identify the most vulnerable for fatal Covid-19 among the oldest and frailest. This information is of importance for future strategies to protect vulnerable populations against neutralization resistant variants of concern.Funding Swedish Research Council, SciLife, Knut and Alice Wallenberg Foundation and Vinnova..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 25. Feb. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vikström, Linnea [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.02.16.23286009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI038756250 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI038756250 | ||
| 003 | DE-627 | ||
| 005 | 20230226225007.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.02.16.23286009 |2 doi | |
| 035 | |a (DE-627)XBI038756250 | ||
| 035 | |a (biorXiv)10.1101/2023.02.16.23286009 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vikström, Linnea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Background To inform future preventive measures including repeated vaccinations, we have searched for a clinically useful immune correlate of protection against fatal Covid-19 among nursing homes residents.Methods We performed repeated capillary blood sampling with analysis of S-binding IgG in an open cohort study with inclusion of nursing home residents in Sweden. We analyzed immunological and registry data collected from September 2021 with end of follow-up 31 August 2022. The study period included implementation of the 3rd and 4th mRNA monovalent vaccine doses and Omicron virus waves.Findings A total of 3012 nursing home residents with median age 86 were enrolled. The 3rd mRNA dose elicited a 99-fold relative increase of S-binding IgG among 2606 blood-sampled individuals and corresponding increase of neutralizing antibodies. The 4th mRNA vaccine dose boosted the levels 3.8-fold. Half-life of S-binding IgG was 72 days. A total 528 residents acquired their first SARS-CoV-2 infection after the 3rd or the 4th vaccine dose and the 30-day mortality was 9.1%. We found no indication that levels of vaccine-induced antibodies protected against infection with Omicron VOCs. In contrast, the risk of death was inversely correlated to levels of S-directed IgG below the 20thpercentile. The risk plateaued at population average above lower 35th percentile of S-binding IgG.Interpretation In the absence of neutralizing antibodies that protection from infection, quantification of S-binding IgG post vaccination may be useful to identify the most vulnerable for fatal Covid-19 among the oldest and frailest. This information is of importance for future strategies to protect vulnerable populations against neutralization resistant variants of concern.Funding Swedish Research Council, SciLife, Knut and Alice Wallenberg Foundation and Vinnova. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Fjällström, Peter |4 aut | |
| 700 | 1 | |a Gwon, Yong-Dae |4 aut | |
| 700 | 1 | |a Sheward, Daniel J. |4 aut | |
| 700 | 1 | |a Wigren-Byström, Julia |4 aut | |
| 700 | 1 | |a Evander, Magnus |4 aut | |
| 700 | 1 | |a Bladh, Oscar |4 aut | |
| 700 | 1 | |a Widerström, Michael |4 aut | |
| 700 | 1 | |a Molnar, Christian |4 aut | |
| 700 | 1 | |a Rasmussen, Gunlög |4 aut | |
| 700 | 1 | |a Bennet, Louise |4 aut | |
| 700 | 1 | |a Åberg, Mikael |4 aut | |
| 700 | 1 | |a Björk, Jonas |0 (orcid)0000-0003-1883-2000 |4 aut | |
| 700 | 1 | |a Tevell, Staffan |4 aut | |
| 700 | 1 | |a Thålin, Charlotte |4 aut | |
| 700 | 1 | |a Blom, Kim |4 aut | |
| 700 | 1 | |a Klingström, Jonas |4 aut | |
| 700 | 1 | |a Murrell, Benjamin |4 aut | |
| 700 | 1 | |a Ahlm, Clas |4 aut | |
| 700 | 1 | |a Normark, Johan |4 aut | |
| 700 | 1 | |a Johansson, Anders F |4 aut | |
| 700 | 1 | |a Forsell, Mattias NE |0 (orcid)0000-0001-6904-742X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 25. Feb. |
| 773 | 1 | 8 | |g year:2023 |g day:25 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.02.16.23286009 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 25 |c 02 | ||